Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata.
Narrow mutational signatures drive acquisition of multidrug resistance in the fungal pathogen Candida glabrata.
复制标题
DOI:
10.1016/j.cub.2021.09.084
复制
发表时间:
2021-12-06
期刊:
影响因子:
--
通讯作者:
Gabaldón T
中科院分区:
文献类型:
--
作者:
Ksiezopolska E;Schikora-Tamarit MÀ;Beyer R;Nunez-Rodriguez JC;Schüller C;Gabaldón T
Fungal infections are a growing medical concern, in part due to increased resistance to one or multiple antifungal drugs. However, the evolutionary processes underpinning the acquisition of antifungal drug resistance are poorly understood. Here, we used experimental microevolution to study the adaptation of the yeast pathogen Candida glabrata to fluconazole and anidulafungin, two widely used antifungal drugs with different modes of action. Our results show widespread ability of rapid adaptation to one or both drugs. Resistance, including multidrug resistance, is often acquired at moderate fitness costs and mediated by mutations in a limited set of genes that are recurrently and specifically mutated in strains adapted to each of the drugs. Importantly, we uncover a dual role of ERG3 mutations in resistance to anidulafungin and cross-resistance to fluconazole in a subset of anidulafungin-adapted strains. Our results shed light on the mutational paths leading to resistance and cross-resistance to antifungal drugs. The ability for fast acquisition of drug resistance is widespread in Candida glabrata Resistance-conferring mutations are very diverse but affect a small number of genes Cross-resistance to fluconazole is common in strains adapted to anidulafungin ERG3 mutations often drive fluconazole resistance in anidulafungin-adapted strains Ksiezopolska et al. trace mutational paths leading to drug resistance in the fungal pathogen Candida glabrata and uncover new resistance-related genes. Importantly, they find that mutations in the ERG3 gene underpin the common appearance of cross-resistance to fluconazole in strains adapted only to anidulafungin.
登录
查看更多内容
影响因子:
3.2
作者:
Gabaldón T;Carreté L
通讯作者:
Carreté L
DOI:
10.3390/antibiotics9120877
发表时间:
2020-12-08
期刊:
Antibiotics (Basel, Switzerland)
影响因子:
--
作者:
Arastehfar A;Gabaldón T;Garcia-Rubio R;Jenks JD;Hoenigl M;Salzer HJF;Ilkit M;Lass-Flörl C;Perlin DS
通讯作者:
Perlin DS
影响因子:
11.3
作者:
Consortium OPATHY;Gabaldón T
通讯作者:
Gabaldón T
DOI:
10.1016/j.cub.2017.11.027
发表时间:
2018-01-08
期刊:
Current biology : CB
影响因子:
--
作者:
Carreté L;Ksiezopolska E;Pegueroles C;Gómez-Molero E;Saus E;Iraola-Guzmán S;Loska D;Bader O;Fairhead C;Gabaldón T
通讯作者:
Gabaldón T
影响因子:
4.9
作者:
Cavalheiro M;Costa C;Silva-Dias A;Miranda IM;Wang C;Pais P;Pinto SN;Mil-Homens D;Sato-Okamoto M;Takahashi-Nakaguchi A;Silva RM;Mira NP;Fialho AM;Chibana H;Rodrigues AG;Butler G;Teixeira MC
通讯作者:
Teixeira MC